Skip to main content

Advertisement

Log in

FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

Data will be available on request from the authors.

References

  1. Rafehi H, Read J, Szmulewicz DJ et al (2023) An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14. Am J Hum Genet 110(1):105–119

    Article  CAS  PubMed  Google Scholar 

  2. Pellerin D, Danzi MC, Wilke C et al (2023) Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. New Eng J Med 388(2):128–141

    Article  CAS  PubMed  Google Scholar 

  3. Poewe W, Stankovic I, Halliday G et al (2022) Multiple system atrophy. Nat Rev Dis Primers 8(1):56

    Article  PubMed  Google Scholar 

  4. Sidoroff V, Bower P, Stefanova N et al (2022) Disease-modifying therapies for multiple system atrophy: where are we in 2022? J Parkinsons Dis 12(5):1369–1387

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wallenius J, Kafantari E, Jhaveri E et al (2023) Exonic trinucleotide repeat expansions in ZFHX3 cause spinocerebellar ataxia type 4: a poly-glycine disease. Am J Hum Genet. https://doi.org/10.1016/j.ajhg.2023.11.008

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Miyatake S, Koshimizu E, Fujita A et al (2022) Rapid and comprehensive diagnostic method for repeat expansion diseases using nanopore sequencing. NPJ Genom Med 7(1):62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hengel H, Pellerin D, Wilke C et al (2023) As Frequent as polyglutamine spinocerebellar ataxias: SCA27B in a large German autosomal dominant ataxia cohort. Mov Disord 38(8):1557–1558

    Article  CAS  PubMed  Google Scholar 

  9. Mizushima K, Shibata Y, Shirai S et al (2024) Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan. J Hum Genet 69(1):27–31

    Article  CAS  PubMed  Google Scholar 

  10. Matsushima M, Yabe I, Sakushima K et al (2021) Multiple system atrophy in Hokkaido, Japan: a prospective registry study of natural history and symptom assessment scales followed for 5 years. BMJ Open 11(2):e045100

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131–1148

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shirai S, Mizushima K, Fujiwara K et al (2023) Case series: downbeat nystagmus in SCA27. J Neurol Sci 454:120849

    Article  CAS  PubMed  Google Scholar 

  13. Wan L, Chen Z, Wan N et al (2020) Biallelic intronic AAGGG expansion of RFC1 is related to multiple system atrophy. Ann Neurol 88(6):1132–1143

    Article  CAS  PubMed  Google Scholar 

  14. Multiple-System Atrophy Research Collaboration (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369(3):233–244

    Article  Google Scholar 

  15. Mitsui J, Matsukawa T, Sasaki H et al (2015) Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol 2(4):417–426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank all the enrolled patients and their families for their cooperation with daily clinical practice and this study, and Rie Nomachi for genetic analyses in Hokkaido University.

Funding

This work was supported by the Japan Agency for Medical Research and Development (AMED) under grant numbers JP23ek0109674, JP23ek0109549, JP23ek0109617, JP23ek0109648, JP23ek0109677 (N. Matsumoto); JSPS KAKENHI under grant numbers JP23H02829 (S. Miyatake) and JP21K07869 (E. Koshimizu); and the Takeda Science Foundation (N. Matsumoto); and the Research Committee on the Medical Basis of Motor Ataxias, Health and Labor Sciences Research Grants, The Ministry of Health, Labor and Welfare, Japan under grant numbers 23FC1010 (I. Yabe.)

Author information

Authors and Affiliations

Authors

Contributions

Drafting of the manuscript: M-M. Patient medical treatment: M-M, A-K, T-M, S-U, A-K, and T-F. Genetic analyses: E-K and S-M. Data analysis: M-M and A-K. Manuscript review for intellectual content: H-Y, E-K, T-M, S-U, S-M, N-M, and I-Y.

Corresponding author

Correspondence to Ichiro Yabe.

Ethics declarations

Conflicts of interest

There were no financial, consulting, or personal relationships with other people or organizations that could influence our study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained for all participants and the study was approved by the institutional review boards of Hokkaido University Hospital and Yokohama City University Faculty of Medicine.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsushima, M., Yaguchi, H., Koshimizu, E. et al. FGF14 GAA repeat expansion and ZFHX3 GGC repeat expansion in clinically diagnosed multiple system atrophy patients. J Neurol (2024). https://doi.org/10.1007/s00415-024-12308-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00415-024-12308-1

Navigation